<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We performed a questionnaire survey about 42 patients with <z:e sem="disease" ids="C0010324" disease_type="Disease or Syndrome" abbrv="">Crigler-Najjar syndrome</z:e> type 1 who were currently alive </plain></SENT>
<SENT sid="1" pm="."><plain>Information was obtained on their age, sex, birth weight, gestation, parental consanguinity, other family members affected, <z:hpo ids='HP_0011007'>age of onset</z:hpo> of <z:hpo ids='HP_0000952'>jaundice</z:hpo>, neonatal and postneonatal <z:chebi fb="0" ids="16990">bilirubin</z:chebi> values, neonatal and postneonatal therapy, problems faced with phototherapy, liver transplantation, current growth status, current neurologic status, and the status of hearing </plain></SENT>
<SENT sid="2" pm="."><plain>Patients were between 2 months and 21 years of age </plain></SENT>
<SENT sid="3" pm="."><plain>There were 18 males and 24 females </plain></SENT>
<SENT sid="4" pm="."><plain>Thirty-nine patients had been born at full term gestation and 3 had been preterm </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0000952'>Jaundice</z:hpo> was noted on postnatal day 1 in 34%, between days 2 and 4 in 55%, and after day 11 of life in 11% of patients </plain></SENT>
<SENT sid="6" pm="."><plain>In the neonatal period <z:chebi fb="0" ids="16990">bilirubin</z:chebi> values (mean +/- SD) were typically 19.8 +/- 4.5 mg/dL </plain></SENT>
<SENT sid="7" pm="."><plain>Eighty-six percent of patients had neonatal peak <z:chebi fb="0" ids="16990">bilirubin</z:chebi> values of &gt;20 mg/dL </plain></SENT>
<SENT sid="8" pm="."><plain>Parental consanguinity was present in 44% and a history of <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's disease</z:e> in one parent was present in 10% of patients </plain></SENT>
<SENT sid="9" pm="."><plain>Causes of exacerbations of <z:hpo ids='HP_0000952'>jaundice</z:hpo> reported were <z:hpo ids='HP_0011947'>respiratory infections</z:hpo>, febrile illnesses, vaccinations, fasting, surgery, <z:e sem="disease" ids="C0086209" disease_type="Mental or Behavioral Dysfunction" abbrv="">emotional stress</z:e>, and noncompliance with treatment </plain></SENT>
<SENT sid="10" pm="."><plain>Neonatal therapy consisted of exchange transfusion in 28%, phototherapy in 79%, <z:chebi fb="0" ids="8069">phenobarbitone</z:chebi> in 20%, and cholestyramine, albumin, infusions, and plasmapheresis in one case each </plain></SENT>
<SENT sid="11" pm="."><plain>The mainstay of postneonatal therapy was home phototherapy for 10 to 16 hours, primarily at night during sleep, using blue lights or a combination of blue and fluorescent lights </plain></SENT>
<SENT sid="12" pm="."><plain>Some patients used innovatively designed phototherapy units </plain></SENT>
<SENT sid="13" pm="."><plain>Problems reported with phototherapy were decreased effectiveness with age, poor compliance, restriction of activity and play, inability to travel or take vacations, irritation from eye shades, difficulty keeping eye protection on, difficulties in temperature maintenance, tanning of the skin, embarrassment from the need to be nearly <z:mp ids='MP_0003815'>nude</z:mp> during phototherapy, and difficulty in procuring phototherapy lamps </plain></SENT>
<SENT sid="14" pm="."><plain>Other therapies that had been tried included oral agar, albumin infusions, <z:chebi fb="11" ids="22586">antioxidants</z:chebi>, acupuncture, <z:chebi fb="0" ids="16990">bilirubin</z:chebi> oxidase, calcium infusions, <z:chebi fb="0" ids="3750">clofibrate</z:chebi>, cruciferous vegetables, cholestyramine, <z:chebi fb="6" ids="3647">chlorpromazine</z:chebi>, flumecinol, plasmapheresis, tin mesoporphyrin, <z:chebi fb="1" ids="9907">ursodeoxycholic acid</z:chebi>, and urinary alkalinization </plain></SENT>
<SENT sid="15" pm="."><plain>Fifteen children had undergone liver transplantation (5 auxiliary and 10 orthotopic) </plain></SENT>
<SENT sid="16" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> 42 patients are reportedly of <z:mpath ids='MPATH_458'>normal</z:mpath> height and weight </plain></SENT>
<SENT sid="17" pm="."><plain>Neurodevelopmental status is said to be <z:mpath ids='MPATH_458'>normal</z:mpath> in 77% of patients </plain></SENT>
<SENT sid="18" pm="."><plain>Two patients have <z:hpo ids='HP_0001343'>kernicterus</z:hpo>, 4 have cerebellar symptoms, and 1 each has <z:hpo ids='HP_0001263'>developmental delay</z:hpo>, mild <z:hpo ids='HP_0002080'>intention tremor</z:hpo>, and mild <z:hpo ids='HP_0000750'>speech delay</z:hpo> </plain></SENT>
<SENT sid="19" pm="."><plain>Hearing was reported to be <z:mpath ids='MPATH_458'>normal</z:mpath> in 94% of patients </plain></SENT>
<SENT sid="20" pm="."><plain>The 2 children with hearing loss have conductive loss from <z:hpo ids='HP_0000388'>otitis media</z:hpo> </plain></SENT>
<SENT sid="21" pm="."><plain>With home phototherapy prolonged, survival free of neurologic deficits is possible in <z:e sem="disease" ids="C0010324" disease_type="Disease or Syndrome" abbrv="">Crigler-Najjar syndrome</z:e> type 1, but there are many problems associated with phototherapy </plain></SENT>
<SENT sid="22" pm="."><plain>Avoiding exacerbations of <z:hpo ids='HP_0000952'>jaundice</z:hpo> is an important aspect of management </plain></SENT>
<SENT sid="23" pm="."><plain>Liver transplantation offers the prospect of cure but its risk versus benefit ratio is undetermined </plain></SENT>
<SENT sid="24" pm="."><plain>Hearing loss was absent in the patients surveyed despite prolonged exposure to high <z:chebi fb="0" ids="16990">bilirubin</z:chebi> levels, which suggests that <z:chebi fb="0" ids="16990">bilirubin</z:chebi> may not be as ototoxic as is commonly believed </plain></SENT>
</text></document>